In the ischemic stroke model, intraperitoneal injection of the P2X4 inhibitor 5‐BDBD significantly reduced the activation of microglia and the expression of P2X4 in the cerebral infarction area, achieving neuroprotection.53 Here, P2RX4 is linked to cerebral infarction.